Literature DB >> 372823

Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder.

H W Herr, N Kemeny, A Yagoda, W F Whitmore.   

Abstract

A randomized prospective therapeutic trial of poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder is presented. Poly I:C had no beneficial effect on the recurrence rate of superficial bladder tumors.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 372823

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


  5 in total

1.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma.

Authors:  D D Mickey
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.

Authors:  W G Walsh; P Tomashefsky; C A Olsson; R deVere White
Journal:  Urol Res       Date:  1983

4.  Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma.

Authors:  D L Lamm; J A Reyna; D F Reichert
Journal:  Urol Res       Date:  1981

Review 5.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.